Latest Breaking News On - Joseph rayne - Page 1 : comparemela.com

Omega Therapeutics Announces Pricing of Initial Public Offering News provided by Share this article Share this article CAMBRIDGE, Mass, July 29, 2021 /PRNewswire/ Omega Therapeutics, Inc. (Nasdaq: OMGA) ( Omega ), a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming™ platform to harness the power of epigenetics to develop a new class of DNA-sequence-targeting, mRNA-encoded programmable epigenetic medicines, today announced the pricing of its initial public offering of 7,400,000 shares of its common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by Omega. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Omega, are expected to be approximately $125.8 million, excluding any exercise of the underwriters option to purchase additional shares. Omega s common stock is expected to begin trading on the Nasdaq

New yorkUnited statesUnited kingdomDavid rosenWedbush pacgrowJoseph raynePiper sandlerExchange commissionProspectus departmentEquity syndicate prospectus departmentGoldman sachs coPiper sandler coPrnewswire omega therapeutics incNasdaq global select marketGoldman sachsபுதியது யார்க்